Terms: = Thyroid cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
43 results:
1. Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies.
Giolito MV; Bodoirat S; La Rosa T; Reslinger M; Guardia GDA; Mourtada J; Claret L; Joung A; Galante PAF; Penalva LOF; Plateroti M
Cell Death Dis; 2024 May; 15(5):306. PubMed ID: 38693105
[TBL] [Abstract] [Full Text] [Related]
2. Integration of scRNA and bulk RNA-sequence to construct the 5-gene molecular prognostic model based on the heterogeneity of thyroid carcinoma endothelial cell.
Ni Z; Cong S; Li H; Liu J; Zhang Q; Wei C; Pan G; He H; Liu W; Mao A
Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):255-269. PubMed ID: 38186223
[TBL] [Abstract] [Full Text] [Related]
3. Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1.
Guo Y; Cui J; Liang X; Chen T; Lu C; Peng T
Int Immunopharmacol; 2024 Jan; 127():111407. PubMed ID: 38134594
[TBL] [Abstract] [Full Text] [Related]
4. Association of abcg2 Polymorphisms on Triple Negative Breast cancer (TNBC) Susceptibility Risk.
Hao Ing Y; Md Salleh MS; Yahya MM; Ankathil R; Abdul Aziz AA
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3891-3897. PubMed ID: 38019248
[TBL] [Abstract] [Full Text] [Related]
5. USP10 suppresses abcg2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway.
Sun J; Xiang Q; Ding D; Yan N
J Bioenerg Biomembr; 2023 Dec; 55(6):457-466. PubMed ID: 37919637
[TBL] [Abstract] [Full Text] [Related]
6. Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced thyroid cancer.
Cantara S; Dalmiglio C; Marzocchi C; Sagnella A; Brilli L; Trimarchi A; Maino F; Valerio L; Castagna MG
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982571
[TBL] [Abstract] [Full Text] [Related]
7. Regulation of cancer stem cell activity by thyroid hormone receptor β.
Lee WK; Zhu X; Park S; Zhu YJ; Zhao L; Meltzer P; Cheng SY
Oncogene; 2022 Apr; 41(16):2315-2325. PubMed ID: 35256781
[TBL] [Abstract] [Full Text] [Related]
8. Impact of transforming growth factor beta 1 on normal and thyroid cancer side population cells.
Latar NM; Mahkamova K; Elson J; Karnik I; Sutherland R; Aspinall S; Meeson A
Endocrine; 2022 May; 76(2):359-368. PubMed ID: 35118633
[TBL] [Abstract] [Full Text] [Related]
9. Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast cancer Cell Lines MDA-MB-453 and MCF-7.
Terasaki A; Kurokawa H; Ito H; Komatsu Y; Matano D; Terasaki M; Bando H; Hara H; Matsui H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333736
[TBL] [Abstract] [Full Text] [Related]
10. Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2
Yi J; Chen S; Yi P; Luo J; Fang M; Du Y; Zou L; Fan P
Oncol Res; 2020 Dec; 28(5):519-531. PubMed ID: 32727638
[TBL] [Abstract] [Full Text] [Related]
11. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer.
Di Desidero T; Orlandi P; Gentile D; Banchi M; Alì G; Kusmic C; Armanetti P; Cayme GJ; Menichetti L; Fontanini G; Francia G; Bocci G
Pharmacol Res; 2020 Aug; 158():104920. PubMed ID: 32461187
[TBL] [Abstract] [Full Text] [Related]
12. A Case of Hashimoto's thyroiditis with Multiple Drug Resistance and High Expression of Efflux Transporters.
Yoshida T; Nakayama A; Tamura A; Higuchi S; Sakuma I; Nagano H; Felizola SJ; Hashimoto N; Takemoto M; Tatsuno I; Koide H; Yokote K; Tanaka T
J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31614366
[TBL] [Abstract] [Full Text] [Related]
13. The Role of ATP-Binding Cassette Transporters in the Chemoresistance of Anaplastic thyroid cancer: A Systematic Review.
Abbasifarid E; Sajjadi-Jazi SM; Beheshtian M; Samimi H; Larijani B; Haghpanah V
Endocrinology; 2019 Aug; 160(8):2015-2023. PubMed ID: 31271419
[TBL] [Abstract] [Full Text] [Related]
14. Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer.
Ozeki T; Nagahama M; Fujita K; Suzuki A; Sugino K; Ito K; Miura M
Sci Rep; 2019 Apr; 9(1):5404. PubMed ID: 30931962
[TBL] [Abstract] [Full Text] [Related]
15. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
[TBL] [Abstract] [Full Text] [Related]
16. miRNA-106a Promotes Breast cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity.
You F; Luan H; Sun D; Cui T; Ding P; Tang H; Sun D
DNA Cell Biol; 2019 Feb; 38(2):198-207. PubMed ID: 30570350
[TBL] [Abstract] [Full Text] [Related]
17. O-GlcNAcylation of GLI transcription factors in hyperglycemic conditions augments Hedgehog activity.
Das S; Bailey SK; Metge BJ; Hanna A; Hinshaw DC; Mota M; Forero-Torres A; Chatham JC; Samant RS; Shevde LA
Lab Invest; 2019 Feb; 99(2):260-270. PubMed ID: 30420690
[TBL] [Abstract] [Full Text] [Related]
18. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
Vella V; Nicolosi ML; Cantafio P; Massimino M; Lappano R; Vigneri P; Ciuni R; Gangemi P; Morrione A; Malaguarnera R; Belfiore A
Endocr Relat Cancer; 2019 Jan; 26(1):197-214. PubMed ID: 30121624
[TBL] [Abstract] [Full Text] [Related]
19. abcg2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib.
Werbrouck E; Bastin J; Lambrechts D; Verbiest A; Van Brussel T; Lerut E; Machiels JP; Verschaeve V; Richard V; Debruyne PR; Decallonne B; Schöffski P; Bechter O; Wolter P; Beuselinck B
Acta Clin Belg; 2019 Jun; 74(3):180-188. PubMed ID: 29792121
[TBL] [Abstract] [Full Text] [Related]
20. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.
Milošević Z; Banković J; Dinić J; Tsimplouli C; Sereti E; Dragoj M; Paunović V; Milovanović Z; Stepanović M; Tanić N; Dimas K; Pešić M
Cell Oncol (Dordr); 2018 Aug; 41(4):409-426. PubMed ID: 29790111
[TBL] [Abstract] [Full Text] [Related]
[Next]
